Read about PREVENTABLE in the news and the importance of this study in understanding the role and benefits of statins for older adults.
June 1st 2021
Community grants are now available from the PREVENTABLE trial. These mini-grants are designed to provide support of educational outreach strategies to diverse communities around disability, dementia or healthy aging.
We are seeking non-profit and community-serving organizations, faith based organizations, tribal nations and other organizations to assist us in expanding our reach to engage those interested in participating in PREVENTABLE.
These awards will provide financial support to community groups with trusted relationships and demonstrated success in engaging seniors in underserved communities, as a complement to local PREVENTABLE Study site engagement efforts. Priority will be given to applicants with demonstrated success in reaching communities of color and rural communities.
For more information, watch this webinar
Applications due: July 15, 2021
April 6th 2021
Eileen Lundin, a retired nurse in Texas, shares why she joined PREVENTABLE to help researchers understand if a common drug to lower cholesterol can also help prevent disability or dementia.
"And there's nothing worse than seeing people that I know, my age group, who are starting to head down the slippery slope to dementia," Lundin says. "It's an awful, awful situation."
Apr 1, 2021
Dr. Catherine McNeal, a principal investigator for PREVENTABLE at Baylor Scott & White, said the long-term length of the study was important due to the nature of mental diseases.
"It takes several years to see improvement or worsening in cognition usually," McNeal said. "So the small studies that we have show that statins seem to prevent against dementia. This study is a very large national study aimed to really address that question, and we hope that it will show what is good for the heart is good for the brain."
March 11th, 2021
Between five and six million Americans age 65 and older live with dementia, a form of memory loss most often caused by Alzheimer's disease. Anyone facing their retirement years undoubtedly hopes to avoid similar cognitive decline and the challenges of daily life that often follow.
"We're hoping to learn one way or another if statins will be beneficial for seniors in maintaining longevity without disability," said Raj Shah, MD, a geriatrician and associate professor of family medicine with the Rush Alzheimer's Disease Center at Rush University in Chicago.
Dec 16, 2020
According to a March 2020 report by the Alzheimer's Association, Black Americans are about twice as likely as white Americans to have Alzheimer's and other dementias, but are only 34% more likely to be diagnosed. While genetic factors play a role in the risk of Alzheimer's,
studies have not found a direct correlation between this and dementia risk regarding race. However, health, socioeconomic factors, stressors and comorbidity also play a role in the disproportionate number of Black Americans who suffer from Alzheimer's.
At the University of Miami, Dr. Olveen Carrasquillo, chief of general medicine, is looking is looking to prioritize minority participation in PREVENTABLE. "We know minorities are disproportionately affected, yet all the studies don't sample enough minorities, so we don't know."
October 29, 2020
This AARP article highlights how research shows that statins, cholesterol-lowering drugs, deserve a closer look in older age. An individual's body doesn't suddenly change when you turn 75 years of age and a slew of recent studies suggest that older adults may benefit from taking a statin. However, there are no clear guidelines on statin use after 75.
September 21, 2020
NY Times Well writer Jane Brody considers statin use for primary prevention in older adults in her Sept 21 article "For Older People, Reassuring News in the Statin Debate." She discusses potentially favorable effects on cognition and cancer, but stresses that evidence from randomized high quality trials is needed. The STAREE trial in Australia and the PREVENTABLE trial in the US will provide this high quality trial evidence.